Synergistic benefit in inflammatory arthritis by targeting IκB kinase ϵ and interferon β
Corr, M, Boyle, D L, Ronacher, L, Flores, N, Firestein, G S
Published in Annals of the rheumatic diseases (01.02.2009)
Published in Annals of the rheumatic diseases (01.02.2009)
Get full text
Journal Article
Interleukin 1 receptor antagonist mediates the beneficial effects of systemic interferon beta in mice: implications for rheumatoid arthritis
Corr, Maripat, Boyle, David L, Ronacher, Lisa M, Lew, Brian R, van Baarsen, Lisa G, Tak, Paul P, Firestein, Gary S
Published in Annals of the rheumatic diseases (01.05.2011)
Published in Annals of the rheumatic diseases (01.05.2011)
Get full text
Journal Article
Synergistic benefit in inflammatory arthritis by targeting I[kappa]B kinase [epsilon] and interferon [beta]
Corr, M, Boyle, D L, Ronacher, L, Flores, N, Firestein, G S
Published in Annals of the rheumatic diseases (01.02.2009)
Published in Annals of the rheumatic diseases (01.02.2009)
Get full text
Journal Article
Synergistic benefit in inflammatory arthritis by targeting I kappaB kinase epsilon and interferon beta
Corr, M, Boyle, D L, Ronacher, L, Flores, N, Firestein, G S
Published in Annals of the rheumatic diseases (01.02.2009)
Published in Annals of the rheumatic diseases (01.02.2009)
Get full text
Journal Article